389 related articles for article (PubMed ID: 26374840)
21. Cyclic AMP Response Element Binding Protein Mediates Pathological Retinal Neovascularization via Modulating DLL4-NOTCH1 Signaling.
Singh NK; Kotla S; Kumar R; Rao GN
EBioMedicine; 2015 Nov; 2(11):1767-84. PubMed ID: 26870802
[TBL] [Abstract][Full Text] [Related]
22. Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization.
Wang Z; Cheng R; Lee K; Tyagi P; Ding L; Kompella UB; Chen J; Xu X; Ma JX
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):855-64. PubMed ID: 25657312
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-Based Therapy of GATA2-Deficient Vascular Disease.
Hartmann D; Fiedler J; Sonnenschein K; Just A; Pfanne A; Zimmer K; Remke J; Foinquinos A; Butzlaff M; Schimmel K; Maegdefessel L; Hilfiker-Kleiner D; Lachmann N; Schober A; Froese N; Heineke J; Bauersachs J; Batkai S; Thum T
Circulation; 2016 Dec; 134(24):1973-1990. PubMed ID: 27780851
[TBL] [Abstract][Full Text] [Related]
24. Repression of choroidal neovascularization through actin cytoskeleton pathways by microRNA-24.
Zhou Q; Anderson C; Zhang H; Li X; Inglis F; Jayagopal A; Wang S
Mol Ther; 2014 Feb; 22(2):378-389. PubMed ID: 24297048
[TBL] [Abstract][Full Text] [Related]
25. Newly Identified Peptide, Peptide Lv, Promotes Pathological Angiogenesis.
Shi L; Zhao M; Abbey CA; Tsai SH; Xie W; Pham D; Chapman S; Bayless KJ; Hein TW; Rosa RH; Ko ML; Kuo L; Ko GY
J Am Heart Assoc; 2019 Nov; 8(22):e013673. PubMed ID: 31698979
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs and the HIF/VEGF axis in ocular neovascular diseases.
Plastino F; Pesce NA; André H
Acta Ophthalmol; 2021 Dec; 99(8):e1255-e1262. PubMed ID: 33729690
[TBL] [Abstract][Full Text] [Related]
27. Myeloid-Derived Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor Are Dispensable for Ocular Neovascularization--Brief Report.
Liyanage SE; Fantin A; Villacampa P; Lange CA; Denti L; Cristante E; Smith AJ; Ali RR; Luhmann UF; Bainbridge JW; Ruhrberg C
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):19-24. PubMed ID: 26603154
[TBL] [Abstract][Full Text] [Related]
28. Circular Noncoding RNA HIPK3 Mediates Retinal Vascular Dysfunction in Diabetes Mellitus.
Shan K; Liu C; Liu BH; Chen X; Dong R; Liu X; Zhang YY; Liu B; Zhang SJ; Wang JJ; Zhang SH; Wu JH; Zhao C; Yan B
Circulation; 2017 Oct; 136(17):1629-1642. PubMed ID: 28860123
[TBL] [Abstract][Full Text] [Related]
29. Apratoxin S4 Inspired by a Marine Natural Product, a New Treatment Option for Ocular Angiogenic Diseases.
Qiu B; Tan A; Veluchamy AB; Li Y; Murray H; Cheng W; Liu C; Busoy JM; Chen QY; Sistla S; Hunziker W; Cheung CMG; Wong TY; Hong W; Luesch H; Wang X
Invest Ophthalmol Vis Sci; 2019 Jul; 60(8):3254-3263. PubMed ID: 31361305
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory role of miR-203 in the angiogenesis of mice with pathological retinal neovascularization disease through downregulation of SNAI2.
Yu L; Wu S; Che S; Wu Y; Han N
Cell Signal; 2020 Jul; 71():109570. PubMed ID: 32084532
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of ocular neovascularization by novel anti-angiogenic compound.
Gau D; Vignaud L; Francoeur P; Koes D; Guillonneau X; Roy P
Exp Eye Res; 2021 Dec; 213():108861. PubMed ID: 34822853
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA expression profile in retina and choroid in oxygen-induced retinopathy model.
Desjarlais M; Rivera JC; Lahaie I; Cagnone G; Wirt M; Omri S; Chemtob S
PLoS One; 2019; 14(6):e0218282. PubMed ID: 31188886
[TBL] [Abstract][Full Text] [Related]
33. Frizzled 4 is required for retinal angiogenesis and maintenance of the blood-retina barrier.
Paes KT; Wang E; Henze K; Vogel P; Read R; Suwanichkul A; Kirkpatrick LL; Potter D; Newhouse MM; Rice DS
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6452-61. PubMed ID: 21743011
[TBL] [Abstract][Full Text] [Related]
34. Lack of netrin-4 modulates pathologic neovascularization in the eye.
Kociok N; Crespo-Garcia S; Liang Y; Klein SV; Nürnberg C; Reichhart N; Skosyrski S; Moritz E; Maier AK; Brunken WJ; Strauß O; Koch M; Joussen AM
Sci Rep; 2016 Jan; 6():18828. PubMed ID: 26732856
[TBL] [Abstract][Full Text] [Related]
35. RORα modulates semaphorin 3E transcription and neurovascular interaction in pathological retinal angiogenesis.
Sun Y; Liu CH; Wang Z; Meng SS; Burnim SB; SanGiovanni JP; Kamenecka TM; Solt LA; Chen J
FASEB J; 2017 Oct; 31(10):4492-4502. PubMed ID: 28646017
[TBL] [Abstract][Full Text] [Related]
36. Nrf2 Activator RS9 Suppresses Pathological Ocular Angiogenesis and Hyperpermeability.
Nakamura S; Noguchi T; Inoue Y; Sakurai S; Nishinaka A; Hida Y; Masuda T; Nakagami Y; Horai N; Tsusaki H; Hara H; Shimazawa M
Invest Ophthalmol Vis Sci; 2019 May; 60(6):1943-1952. PubMed ID: 31050722
[TBL] [Abstract][Full Text] [Related]
37. Fzd7 (Frizzled-7) Expressed by Endothelial Cells Controls Blood Vessel Formation Through Wnt/β-Catenin Canonical Signaling.
Peghaire C; Bats ML; Sewduth R; Jeanningros S; Jaspard B; Couffinhal T; Duplàa C; Dufourcq P
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2369-2380. PubMed ID: 27758766
[TBL] [Abstract][Full Text] [Related]
38. Ras pathway inhibition prevents neovascularization by repressing endothelial cell sprouting.
Westenskow PD; Kurihara T; Aguilar E; Scheppke EL; Moreno SK; Wittgrove C; Marchetti V; Michael IP; Anand S; Nagy A; Cheresh D; Friedlander M
J Clin Invest; 2013 Nov; 123(11):4900-8. PubMed ID: 24084735
[TBL] [Abstract][Full Text] [Related]
39. Direct repression of IGF2 is implicated in the anti-angiogenic function of microRNA-210 in human retinal endothelial cells.
Yang Q; Wang P; Du X; Wang W; Zhang T; Chen Y
Angiogenesis; 2018 May; 21(2):313-323. PubMed ID: 29335842
[TBL] [Abstract][Full Text] [Related]
40. SNAI1, an endothelial-mesenchymal transition transcription factor, promotes the early phase of ocular neovascularization.
Sun JX; Chang TF; Li MH; Sun LJ; Yan XC; Yang ZY; Liu Y; Xu WQ; Lv Y; Su JB; Liang L; Han H; Dou GR; Wang YS
Angiogenesis; 2018 Aug; 21(3):635-652. PubMed ID: 29675549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
